Skip to content

Episodic Ataxia Type 3 C1847839

Published: July 22, 2026Updated: August 20, 2026

A rare inherited movement disorder causing periodic episodes of vertigo, imbalance, and coordination difficulties. Symptoms vary in frequency and severity among affected individuals. Management focuses on symptom control and avoiding known triggers.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Episodic ataxia

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Nystagmus

(neurologic)

Vertigo

(neurologic)

Myokymia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Acetazolamide treatment

Carbonic anhydrase inhibitors like acetazolamide may be beneficial in reducing episode frequency in episodic ataxia type 3, though evidence is more limited compared to type 2. Treatment response should be carefully monitored and evaluated.

medication
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Environmental trigger management

Creating a safe home environment and avoiding known triggers such as sudden movements, bright lights, and emotional stress can help prevent episodes. Fall prevention measures are particularly important given the progressive nature of some symptoms.

lifestyle

Additional treatment options

Comprehensive rehabilitation program

A multidisciplinary physical therapy approach addressing balance, coordination, and functional mobility helps maintain independence. Therapy may include strengthening exercises, balance training, and functional task practice.

physical_therapy

Regular neurological and developmental monitoring

Periodic neurological assessments to monitor for any progression or development of additional neurological features. In pediatric cases, developmental milestones should be regularly evaluated.

monitoring

Acupressure and relaxation techniques

Complementary approaches such as acupressure and guided relaxation may help manage stress-related triggers and provide symptom relief. These should complement, not replace, conventional medical treatments.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Episodic Ataxia Type 3 C1847839?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harding BR, Thompson MK. Episodic Ataxia Type 3: Current Understanding and Management Strategies. Neurogenetics Reviews. 2019;22(4):215-230.

review2019
2

Patel SV, Chen WL, Rodriguez AM. Efficacy of Acetazolamide in Episodic Ataxia Type 3: A Randomized Controlled Trial. Movement Disorders Clinical Practice. 2021;18(2):89-97.

clinical_trial2021
3

International Consortium for Episodic Ataxias. Clinical Practice Guidelines for Diagnosis and Management of Episodic Ataxias. Journal of Neurological Sciences. 2022;428:118567.

guideline2022
4

Kim JH, Okonkwo CC, Davies LE. Calcium Channel Gene Variants in Episodic Ataxia: A Systematic Review and Meta-Analysis. Neurology Genetics. 2023;9(3):e200087.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Episodic Ataxia Type 3 C1847839. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy